Roche announced that the European Commission has extended the marketing authorisation for Actemra®/RoActemra® (tocilizumab) to include the treatment of COVID-19...
Read moreFareva and ApiJect Systems, Corp. announced a 10-year licensing agreement to install three Blow-Fill-Seal production lines that when operational will...
Read moreCASI Pharmaceuticals, Inc., a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announces that the...
Read moreFor injectable medications, the shift from preclinical to clinical development is one of the most important transitions in the development...
Read moreTwist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform,...
Read moreAbbVie and the University of Chicago and have extended their collaboration agreement through 2025 to support preclinical oncology research. To...
Read moreRegeneron Pharmaceuticals, Inc. announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted...
Read moreGerresheimer acquired the IP of a new generation cartridge based autoinjector from Midas Pharma. This is the start of a...
Read moreBeximco Pharmaceuticals Limited, the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, announces the launch of the world's...
Read moreBiognosys, a leader in proteomics solutions for drug discovery and development, announces the launch of its next-generation blood biomarker discovery...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.